Drugs Made IN America Acquisition Corp. Rights DMAAR

$0.15 0.00 (-0.66%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
133,600
Avg volume
—
Day's range
$0.15 – $0.15
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Phone
646 726 7074
Address
420 Lexington Avenue, Suite 1402, New York, United States

Latest news

No headlines yet.